PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

47,931 stories, page 18 of 799

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Limited (TEVA.TA) Stock Price, News, Quote & History

Yahoo! Finance CanadaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is biotech beauty the big thing in skincare? Expert explains the rise of science-backed ingredients

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Minister addresses concerns about biotech development, disaster prevention funding

vietnamnews.vnOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Anthropic’s one-person biotech buy; Jake Van Naarden’s dealmaking strategy; and more

Endpoints NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Elon Musk Backs Eli Lilly’s Drug Pipeline as CEO Dave Ricks Challenges Big Biotech Skepticism - Merck & C

BenzingaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Minister addresses concerns about biotech development, disaster prevention funding

Vietnam+ (VietnamPlus)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

AI is advancing faster than we can explain it. Here's how to separate fact from hype.

Berkshire EagleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RFK Jr. eases access to unproven peptides despite opposition from FDA scientists

KXAN AustinOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Iontophoresis: Machines, Patches and FDA Rules

CASRAIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech Completes Dosing in Phase 2/3 MIRACLE Trial for AnnAraC

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zhimeng Biopharma Completes Enrollment of CB03-154 Phase 2/3 ALS Trial

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PROSpect’s Negative Findings Are the Most Important Data in Pediatric Critical Care This Decade

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China's biotechnology sector shifts from manufacturing to exploring pharma innovation

The Nation (Pakistan )Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Somerset County-headquartered pharmaceutical company receives $60.5M in tax credits for expansion, 330 new jobs

WRNJ RadioOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The DOGE Playbook Was Written by Government Itself

RealClearMarketsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zhimeng Biopharma completes enrollment of 255 patients in pivotal Phase 2/3 ALS trial of CB03-154

DealroomOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jinghua Pharmaceutical Group Co., Ltd. Class A Estimates – SZSE:002349

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Limited (TEVA) Stock Price, News, Quote & History

Yahoo! Finance CanadaOriginal source
🇺🇸Researchonlinelibrary.wiley.comTier 2 · Direct publisher

Subcutaneous Defibrillator for Primary Prevention in Chronic Kidney Disease Stage 3–5: The Single‐Arm STEADIED Study

Pacing and Clinical ElectrophysiologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DKSH expands global pharmaceutical portfolio with acquisition of Rocephin rights in 80 markets

Indian Pharma PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Limited (TEVA) stock price, news, quote and history

Yahoo Finance UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GLP-1 Compounding After Drug Shortages

The Regulatory ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial.

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Agios Sinks 18% as FDA Delays Sickle Cell Drug Decision to 2027 Despite Being “Launch-Ready”

TIKR.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc (WPS.SG) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance CanadaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AMA Urges FDA to Hold Botanical Products to Rigorous Safety and Efficacy Standards

Florida Hospital News and Healthcare ReportOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US bans imports from 3 Chinese biotech companies over forced labor allegations

Bluefield Daily TelegraphOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial.

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves Moderna's mRNA seasonal flu vaccine

ABC News - Breaking News, Latest News and VideosOriginal source
🇺🇸Researchsciencedaily.comTier 2 · Direct publisher

A surprising vitamin A discovery is changing what scientists know about vision

ScienceDaily Health RSSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

3 Biotech Stocks With Upside Of Up To 80%

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

4 FDA officials suspended over alleged unauthorised raids in Pune, 21 others to face inquiry

The Economic TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

4 FDA officials suspended over alleged unauthorised raids in Pune, 21 others to face inquiry

ANI NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Examining Trontinemab in Early Alzheimer Disease: The Phase 3 TRONTIER 1 and 2 Trials

NeurologyLiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New database offers insights into psychedelic use outside clinical trials

News-MedicalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Supreme Court asked to restore access to mail-order abortion pill mifepristone

ABC News - Breaking News, Latest News and VideosOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves ILUMYA for adults with psoriatic arthritis — News-Medical

UA.NEWSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

​Meet Esther Wojcicki: This mother raised a YouTube CEO, a biotech entrepreneur, and a doctor; 5 parenting principles this mother swears by​

The Times of IndiaOriginal source
🇺🇸Researchatlasventure.comTier 2 · Direct publisher

The Fruits of AI Drug Abundance: Indigestion In The Near Term

Atlas VentureOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RFK Jr. says FDA will 'act on' petition to reexamine some ingredients in ultra-processed foods

ABC News - Breaking News, Latest News and VideosOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Taiko Pharmaceutical Co.,Ltd. (4574.T) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance CanadaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance CanadaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

META_TITLE_QUOTE

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA inspects 102 drinking water units, shuts 12

The New Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical Inc. (RARE) Stock Price, News, Quote & History

Yahoo! Finance CanadaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Some wellness peptides will become widely available, HHS says

ABC News - Breaking News, Latest News and VideosOriginal source
🇺🇸Researchsciencedaily.comTier 2 · Direct publisher

A simple blood test could reveal Alzheimer’s risk 10 years before symptoms

ScienceDaily Health RSSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Stocktwits Biotech Dealmaker: BioMarin’s Fabry Disease Drug Candidate License Dominates Slow Week In Dealmaking

StocktwitsOriginal source
🇺🇰Researchnature.comTier 2 · Direct publisher

AI-HistoPS: decoding proteomic heterogeneity with subtype resolution from histopathology in liver metastases

npj Precision OncologyOriginal source
🇺🇰Researchnature.comTier 2 · Direct publisher

In vivo frataxin expression of a triplex purified minicircle

Nature Gene TherapyOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Drug Discovery for Snakebite Envenoming: Wanderings Amid Historical Antidotes and Emerging Therapeutic Opportunities

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Advancing Evidence Generation in Small, Diverse, Understudied Population

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Regulatory reforms and the impact on overseas new drug accessibility in China: an analysis from 2010 to 2025

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

A mechanistic quantitative systems pharmacology framework for glucosamine sulfate in knee osteoarthritis: linking exposure, cartilage biology, and clinical outcomes

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Clinical effects of acupuncture for traumatic peripheral nerve injury: a meta-analysis of randomized controlled trials

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Endocrine resistance in HR+/HER2− breast cancer: molecular mechanisms and emerging therapeutic strategies

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Systematic review of atropine cost-effectiveness in childhood myopia management

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Prospective evaluation of combination oral S-1 and intravenous cisplatin in cancer patients with severe hepatic dysfunction – a feasibility, safety, and pharmacokinetic study

Europe PMCOriginal source